PMDA drug package insert
ラナンキュラスぢ軟膏DX
PMDA OTC drug · 企画元：株式会社ツルハグループマーチャンダイジング · package insert Jan 14, 2025
Key facts
| Brand names | ラナンキュラスぢ軟膏DX |
|---|---|
| Companies | 製造販売元／奥田製薬（株）,販売会社／企画元：株式会社ツルハグループマーチャンダイジング |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | 塗布剤 |
| OTC effect category | 外用痔疾用薬 |
| Package insert date | Jan 14, 2025 |
| PMDA document key | 180150_J2001000085 |
| PMDA company code | 180150 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: